Debra C Hawkins

Debra C. Hawkins serves as a Contracting Officer responsible for managing complex procurements in specialized scientific and pharmaceutical manufacturing sectors. In her role, she ensures compliance with federal acquisition regulations while advancing mission-critical acquisitions for analytical instrumentation and pharmaceutical preparation systems. Her procurement portfolio centers on high-precision equipment and formulation technologies, requiring deep technical understanding of laboratory-grade manufacturing standards and regulatory compliance frameworks such as cGMP and ISO 13485. She oversees the full lifecycle of contract actions—from market research and solicitation development to award and performance monitoring—ensuring alignment with agency objectives and statutory requirements. While no specific contractor relationships are currently identifiable in the data, Hawkins engages with a broad spectrum of vendors specializing in analytical laboratory instruments and pharmaceutical formulations, including both large-scale manufacturers and niche technology providers. Her contracting approach emphasizes competitive solicitation, technical evaluation rigor, and performance-based contracting methodologies to ensure reliable delivery of mission-critical equipment and processes. She maintains a vendor-neutral posture, prioritizing technical capability, quality assurance, and supply chain resilience over any single supplier relationship. Hawkins exhibits a strong preference for open competition, with 100% of her acquisitions classified as “No Set-Aside.” This reflects a strategic focus on maximizing technical competition and access to specialized capabilities rather than socioeconomic set-asides. While she does not routinely utilize 8(a), HUBZone, or SDVOSB programs, her procurement strategy supports broad market access, enabling all qualified firms—regardless of size or certification—to compete on technical merit and operational readiness. Her primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 325412 (Pharmaceutical Preparation Manufacturing), indicating deep expertise in procuring chromatography systems, spectrometers, automated synthesis equipment, and sterile drug formulation technologies. She possesses specialized knowledge of FDA-regulated environments and the technical specifications required for precision instrumentation used in research, quality control, and production settings.